🔴 Alzamend Neuro is trading 6% down; no clear catalyst identified

Alzamend Neuro is trading 6.02% lower at $1.25, with no clear company-specific catalyst identified.

• The decline extends the sharp October 1 drop, when shares closed at $1.31, down 23.99%.
• The company’s investor-relations release page lists September 16 as its latest announcement, with no October 2 announcement shown.
• The broader market is higher; available context does not indicate the stock is tracking that positive move. No verified trading-volume details are available.